Skip to main content
William Marston, MD, Vascular Surgery, Chapel Hill, NC, University of North Carolina Hospitals

WilliamAMarstonMD

Vascular Surgery Chapel Hill, NC

Professor of Surgery, University of North Carolina School of Medicine

Dr. Marston is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Marston's full profile

Already have an account?

Education & Training

  • University of North Carolina Hospitals
    University of North Carolina HospitalsFellowship, Vascular Surgery, 1993 - 1995
  • University of North Carolina Hospitals
    University of North Carolina HospitalsResidency, Surgery, 1988 - 1993
  • University of Virginia School of Medicine
    University of Virginia School of MedicineClass of 1988

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 1993 - 2024
  • American Board of Surgery Vascular Surgery

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
  • Fellow (FACS) American College of Surgeons

Clinical Trials

Publications & Presentations

PubMed

Authored Content

  • Importance of Early Saphenous Ablation to Maximize Ulcer-Free Days for Patients with Venous UlcersSeptember 2020
  • Superior Mesenteric and Celiac Artery Stenting Does Not Increase Complication Rate After Fenestrated or Branched Endovascular Aneurysm RepairJanuary 2018
  • Outcomes and Complications After Fenestrated/Branched Endovascular Aortic RepairJanuary 2018

Press Mentions

  • InterVene’s BlueLeaf Endovenous Valve Formation System Granted FDA Breakthrough Device Designation
    InterVene’s BlueLeaf Endovenous Valve Formation System Granted FDA Breakthrough Device DesignationDecember 14th, 2021
  • InterVene’s BlueLeaf Endovenous Valve Formation System Granted FDA Breakthrough Device Designation
    InterVene’s BlueLeaf Endovenous Valve Formation System Granted FDA Breakthrough Device DesignationDecember 13th, 2021
  • Study Explores Early Thrombosis After Iliac Stenting for Venous Outflow Occlusion
    Study Explores Early Thrombosis After Iliac Stenting for Venous Outflow OcclusionNovember 19th, 2021
  • Join now to see all

Professional Memberships

Hospital Affiliations